CEO Robert Lisicki To Take Medical Leave - SEC Filing
10/10/2025 13:23
Zura Bio Ltd ZURA.O: ZURA BIO LTD - CEO ROBERT LISICKI TO TAKE MEDICAL LEAVE - SEC FILING ZURA BIO LTD - KIM DAVIS APPOINTED INTERIM CEO OF CO - SEC FILING Source text: [ID:n0001104659-25-098546] Further company coverage: ZURA.O
Recent news on Zura Bio
See all newsZura Bio Ltd reports results for the quarter ended June 30 - Earnings Summary
Zura Bio Q2 net loss widens as R&D expenses rise
Zura Bio Ltd expected to post a loss of 20 cents a share - Earnings Preview
Brief: Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Zura Bio Expands Leadership Team With Appointment Of Muzammil Mustufa As Chief Business Officer